RECRUITING

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project aims to elucidate the important protective elements of social relationships and identify concrete, modifiable behavioral factors that contribute to biological and phenotypic aging in hematopoietic cell transplantation (HCT) survivors and can be used to develop biologically informed interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging.

Official Title

Accelerated Biological and Phenotypic Aging in Hematopoietic Cell Transplant Survivors: Social Support as a Protective Factor

Quick Facts

Study Start:2021-05-18
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04892823

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 18 years and older who are competent to give their informed consent.
  2. * Ability to read, speak, and understand English.
  3. * Received a hematopoietic cell transplant within the previous 100 days.
  1. * Less then Aged 18 years and older who are competent to give their informed consent.
  2. * Cannot read, speak, and understand English.
  3. * Has not received a hematopoietic cell transplant within the previous 100 days.

Contacts and Locations

Study Contact

Medical College of Wisconsin Cancer Center Clinical Trials Office
CONTACT
866-680-0505
cccto@mcw.edu

Principal Investigator

Kelly Rentscher, PhD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

  • Kelly Rentscher, PhD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-05-18
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2021-05-18
Study Completion Date2025-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hematopoietic and Lymphoid Cell Neoplasm